Amorsolo L Suguitan Jr
Overview
Explore the profile of Amorsolo L Suguitan Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
1282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boonnak K, Matsuoka Y, Wang W, Suguitan Jr A, Chen Z, Paskel M, et al.
J Virol
. 2017 May;
91(15).
PMID: 28490598
We have developed pandemic live attenuated influenza vaccines (pLAIVs) against clade 1 H5N1 viruses on an Ann Arbor cold-adapted () backbone that induced long-term immune memory. In 2015, many human...
2.
Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder L, et al.
Proc Natl Acad Sci U S A
. 2015 Jul;
112(30):9430-5.
PMID: 26170284
H5N1 avian influenza viruses remain a threat to public health mainly because they can cause severe infections in humans. These viruses are widespread in birds, and they vary in antigenicity...
3.
Suguitan Jr A, Zengel J, Jacobson S, Gee S, Cetz J, Cha P, et al.
Influenza Other Respir Viruses
. 2014 Apr;
8(2):169-76.
PMID: 24734293
Objective: The objective was to study passively acquired influenza H1N1 pandemic (H1N1pdm) maternal antibody kinetics and its impact on subsequent influenza infection and vaccination in ferrets during an outbreak of...
4.
Cheng X, Zengel J, Suguitan Jr A, Xu Q, Wang W, Lin J, et al.
J Infect Dis
. 2013 May;
208(4):594-602.
PMID: 23656978
The humoral and cellular immune responses elicited by the trivalent live attenuated influenza vaccine (LAIV) and the trivalent inactivated influenza vaccine (TIV) were evaluated in the ferret model, using newly...
5.
Lakdawala S, Lamirande E, Suguitan Jr A, Wang W, Santos C, Vogel L, et al.
PLoS Pathog
. 2012 Jan;
7(12):e1002443.
PMID: 22241979
The epidemiological success of pandemic and epidemic influenza A viruses relies on the ability to transmit efficiently from person-to-person via respiratory droplets. Respiratory droplet (RD) transmission of influenza viruses requires...
6.
Suguitan Jr A, Matsuoka Y, Lau Y, Santos C, Vogel L, Cheng L, et al.
J Virol
. 2011 Dec;
86(5):2706-14.
PMID: 22205751
Highly pathogenic avian influenza (HPAI) viruses of the H5 and H7 subtypes typically possess multiple basic amino acids around the cleavage site (MBS) of their hemagglutinin (HA) protein, a recognized...
7.
Wang W, Suguitan Jr A, Zengel J, Chen Z, Jin H
Vaccine
. 2011 Dec;
30(5):872-8.
PMID: 22172510
The proteolytic enzyme bromelain has been traditionally used to cleave the hemagglutinin (HA) protein at the C-terminus of the HA2 region to release the HA proteins from influenza virions. The...
8.
Suguitan Jr A, Cheng X, Wang W, Wang S, Jin H, Lu S
PLoS One
. 2011 Jul;
6(7):e21942.
PMID: 21760928
Priming immunization plays a key role in protecting individuals or populations to influenza viruses that are novel to humans. To identify the most promising vaccine priming strategy, we have evaluated...
9.
Wang W, Lu B, Zhou H, Suguitan Jr A, Cheng X, Subbarao K, et al.
J Virol
. 2010 Apr;
84(13):6570-7.
PMID: 20427525
A live attenuated influenza A/Vietnam/1203/2004 (H5N1) vaccine virus (VN04 ca) has receptor binding specificity to alpha2,3-linked sialosides (alpha2,3SAL), and a single dose induces a minimal serum antibody response in mice...
10.
Corti D, Suguitan Jr A, Pinna D, Silacci C, Fernandez-Rodriguez B, Vanzetta F, et al.
J Clin Invest
. 2010 Apr;
120(5):1663-73.
PMID: 20389023
The target of neutralizing antibodies that protect against influenza virus infection is the viral protein HA. Genetic and antigenic variation in HA has been used to classify influenza viruses into...